{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T10:49:41Z","timestamp":1772621381383,"version":"3.50.1"},"reference-count":54,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Vet. Sci."],"abstract":"<jats:p>Mesenchymal stromal cells (MSCs) are recognized for their potent anti-inflammatory, antibacterial, and immunomodulatory properties, making them a promising therapeutic option for combating antibiotic resistance and biofilm-associated infections. This report describes the successful treatment of septic arthritis and osteomyelitis in a foal using equine allogeneic cord blood-derived MSCs (CB-MSCs) in combination with antibiotic therapy. An 8-day-old Thoroughbred filly initially presented with septic arthritis of the right tibiotarsal joint, pneumonia, and omphalophlebitis\/arteritis. Subsequently, the filly developed septic arthritis of the left elbow joint, epiphysitis, and osteomyelitis of the ulna, which progressed to an aggressive pathological fracture. Chloramphenicol was instituted based on the bacterial culture and susceptibility. Due to limited clinical and cytological improvement following needle lavage, arthroscopic lavage, and intra-articular antibiotic administration, the left elbow joint and fracture site were treated three times with 15 million TLR3-activated CB-MSCs in combination with meropenem (7.25\u202fmg\/kg IA). Additionally, the filly received twice systemic treatment with non-activated CB-MSCs (1 million cells\/kg IV). The treatment resulted in complete resolution of both septic arthritis and osteomyelitis. At a 12-month follow-up, the filly remained sound, and radiographic re-evaluation showed significant remodeling of the ulna. This case describes the successful use of equine allogeneic cord blood\u2013derived mesenchymal stromal cells (CB-MSCs), administered locally and systemically in combination with antibiotic therapy, to manage a refractory intra-synovial and osseous septic process in a foal. The use of TLR3-activated CB-MSCs may have supported antimicrobial treatment, highlighting the potential antimicrobial, anti-inflammatory, and immunomodulatory properties of CB-MSCs.<\/jats:p>","DOI":"10.3389\/fvets.2026.1734585","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T05:43:04Z","timestamp":1772602984000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Equine allogeneic umbilical cord blood mesenchymal stromal cells (CB-MSC) as adjunctive therapy in a foal with septic arthritis and osteomyelitis"],"prefix":"10.3389","volume":"13","author":[{"given":"Marta","family":"Horna","sequence":"first","affiliation":[{"name":"Department of Clinical Studies, Ontario Veterinary College, University of Guelph","place":["Guelph, ON, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Merch\u00e1n Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"Department of Clinical Studies, Ontario Veterinary College, University of Guelph","place":["Guelph, ON, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurie","family":"Goodrich","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Colorado State University, College of Veterinary Medicine and Biomedical Sciences","place":["Fort Collins, CO, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynn","family":"Pezzanite","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Colorado State University, College of Veterinary Medicine and Biomedical Sciences","place":["Fort Collins, CO, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Dow","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Colorado State University, College of Veterinary Medicine and Biomedical Sciences","place":["Fort Collins, CO, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"Koch","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Ontario Veterinary College, University of Guelph","place":["Guelph, ON, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amir H.","family":"Alizadeh","sequence":"additional","affiliation":[{"name":"eQcell Inc., University of Guelph","place":["Guelph, ON, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahar","family":"Mehrpouyan","sequence":"additional","affiliation":[{"name":"eQcell Inc., University of Guelph","place":["Guelph, ON, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Koenig","sequence":"additional","affiliation":[{"name":"Department of Clinical Studies, Ontario Veterinary College, University of Guelph","place":["Guelph, ON, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1751-0813.2009.00539.x","article-title":"Retrospective study of 108 foals with septic osteomyelitis","volume":"88","author":"Neil","year":"2010","journal-title":"Aust Vet J"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/eve.13394","article-title":"Haematogenous septic arthritis, physitis and osteomyelitis in foals: a tutorial review on pathogenesis, diagnosis, treatment and prognosis. Part 1. Equine veterinary Education.Part 1","volume":"33","author":"Lindegaard","year":"2021","journal-title":"Equine Vet Educ"},{"key":"ref3","first-page":"37","article-title":"Haematogenous septic arthritis, physitis and osteomyelitis in foals: a tutorial review on pathogenesis, diagnosis, treatment and prognosis. Part 2","volume-title":"Equine Vet Educ","author":"Lindegaard","year":"2022"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1111\/jvim.16671","article-title":"Antibiograms of field and hospital acquired equine neonatal bacterial fluid cultures in the Midwestern United States: 149 samples (2007-2018)","volume":"37","author":"Bookbinder","year":"2023","journal-title":"J Vet Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1053\/j.ctep.2006.09.005","article-title":"Etiology, diagnosis, and treatment of septic arthritis, osteitis, and osteomyelitis in foals","volume":"5","author":"Hardy","year":"2006","journal-title":"Clin Tech Equine Pract"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"785","DOI":"10.2460\/javma.246.7.785","article-title":"Bacterial isolates, antimicrobial susceptibility patterns, and factors associated with infection and outcome in foals with septic arthritis: 83 cases (1998-2013)","volume":"246","author":"Hepworth-Warren","year":"2015","journal-title":"J Am Vet Med Assoc"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"346","DOI":"10.2460\/javma.2003.222.346","article-title":"Intraosseous regional perfusion for treatment of septic physitis in a two-week-old foal","volume":"222","author":"Kettner","year":"2003","journal-title":"J Am Vet Med Assoc"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/evj.13892","article-title":"Prognosis for survival to discharge and racing performance in thoroughbred foals treated for single joint septic arthritis (2009-2016)","volume":"55","author":"Whisenant","year":"2023","journal-title":"Equine Vet J"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/evj.13387","article-title":"Factors associated with survival and racing performance of 114 thoroughbred foals with septic arthritis compared with maternal siblings (2009-2015)","volume":"53","author":"O'Brien","year":"2021","journal-title":"Equine Vet J"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/2046-0481-61-2-102","article-title":"Analysis of factors influencing prognosis in foals with septic arthritis","volume":"61","author":"Vos","year":"2008","journal-title":"Irish Vet J"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1751-0813.2008.00311.x","article-title":"Blood culture isolates and anti-microbial sensitivities from 427 critically ill neonatal foals","volume":"86","author":"Russell","year":"2008","journal-title":"Aust Vet J"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2746\/042516409X480403","article-title":"Bacterial culture of septic synovial structures of horses: does a positive bacterial culture influ ence prognosis?","volume":"42","author":"Taylor","year":"2010","journal-title":"Equine Vet J"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/00480169.2015.1109006","article-title":"Antimicrobial suscepti bility of bacteria isolated from neonatal foal samples submitted to a New Zealand veterinary pathology laboratory (2004-2013)","volume":"64","author":"Toombs-Raune","year":"2016","journal-title":"N Z Vet J"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.21037\/atm-22-1746","article-title":"TLR-activated mesenchymal stromal cell therapy and antibiotics to treat multi-drug resistant staphylococcal septic arthritis in an equine model","volume":"10","author":"Pezzanite","year":"2022","journal-title":"Ann Transl Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.cveq.2023.06.005","article-title":"Antimicrobial properties of equine stromal cells and platelets and future directions","volume":"39","author":"Pezzanite","year":"2023","journal-title":"Vet Clin North Am Equine Pract"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"606404","DOI":"10.3389\/fmicb.2020.606404","article-title":"Mesenchymal stromal cells as potential antimicrobial for veterinary use-a comprehensive review","volume":"11","author":"Russell","year":"2020","journal-title":"Front Microbiol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1089\/scd.2017.0241","article-title":"Comparison of antibacterial and immunological properties of mesenchymal stem\/stromal cells from equine bone marrow, endometrium, and adipose tissue","volume":"27","author":"Cort\u00e9s-Araya","year":"2018","journal-title":"Stem Cells Dev"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.2460\/javma.23.10.0561","article-title":"Targeted transcriptomic analysis of synovial tissues from horses with septic arthritis treated with immune-activated mesenchymal stromal cells reveals induction of T-cell response pathways","volume":"262","author":"Pezzanite","year":"2024","journal-title":"J Am Vet Med Assoc"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.cveq.2023.07.004","article-title":"Use of biologics and stem cells in the treatment of other inflammatory diseases in the horse","volume":"39","author":"Barrett","year":"2023","journal-title":"Vet Clin North Am Equine Pract"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"925701","DOI":"10.3389\/fvets.2022.925701","article-title":"Activated mesenchymal stromal cell therapy for treatment of multi-drug resistant bacterial infections in dogs","volume":"9","author":"Johnson","year":"2022","journal-title":"Front Vet Sci"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/vsu.13628","article-title":"Toll-like receptor activation of equine mesenchymal stromal cells to enhance antibacterial activity and immunomodulatory cytokine secretion","volume":"50","author":"Pezzanite","year":"2021","journal-title":"Vet Surg"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1532-950X.2014.12100.x","article-title":"Clinical outcome after intra-articular administration of bone marrow derived mesenchymal stem cells in 33 horses with stifle injury","volume":"43","author":"Ferris","year":"2014","journal-title":"Vet Surg"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"9575","DOI":"10.1038\/s41598-017-08311-4","article-title":"Activated mesenchymal stem cells interact with antibiotics and host innate immune responses to control chronic bacterial infections","volume":"7","author":"Johnson","year":"2017","journal-title":"Sci Rep"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1002\/stem.544","article-title":"Antibacterial effect of human mesenchymal stem cells is mediated in part from secretion of the antimicrobial peptide LL-37","volume":"28","author":"Krasnodembskaya","year":"2010","journal-title":"Stem Cells"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1472-6750-7-26","article-title":"Isolation of mesenchymal stem cells from equine umbilical cord blood","volume":"7","author":"Koch","year":"2007","journal-title":"BMC Biotechnol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1111\/evj.14531","article-title":"Treatment outcomes for equine osteoarthritis with mesenchymal stromal cells and hyaluronic acid","volume":"57","author":"Luque","year":"2025","journal-title":"Equine Vet J"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1089\/scd.2018.0135","article-title":"Equine cord blood mesenchymal stromal cells have greater differentiation and similar immunosuppressive potential to cord tissue mesenchymal stromal cells","volume":"28","author":"Lepage","year":"2019","journal-title":"Stem Cells Dev"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2020.617647","article-title":"Interactions between allogeneic mesenchymal stromal cells and the recipient immune system: a comparative review with relevance to equine outcomes","volume":"7","author":"Kamm","year":"2021","journal-title":"Front Vet Sci"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/sctm.19-0092","article-title":"Antibacterial activity of human mesenchymal stem cells mediated directly by constitutively secreted factors and indirectly by activation of innate immune effector cells","volume":"9","author":"Chow","year":"2020","journal-title":"Stem Cells Transl Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3390\/life11060519","article-title":"Emerging treatment options for multi-drug-resistant bacterial infections","volume":"11","author":"Giurazza","year":"2021","journal-title":"Life"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"7850","DOI":"10.3390\/ijms22157850","article-title":"Mesenchymal stem cell-based therapy as an alternative to the treatment of acute respiratory distress syndrome: current evidence and future perspectives","volume":"22","author":"Fernandez-Francos","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1302\/2046-3758.111.2000132","article-title":"The horse as a model of naturally occurring osteoarthritis","volume":"1","author":"McIlwraith","year":"2012","journal-title":"Bone Joint Res"},{"key":"ref33","doi-asserted-by":"crossref","DOI":"10.1016\/B978-0-323-48420-6.00086-7","article-title":"Chapter 86 - synovial and osseous infection","volume-title":"Equine surgery (fifth edition)","author":"Richardson","year":"2019"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0034-5288(18)32265-3","article-title":"Micro-angiographic studies of metaphyseal vessels in young foals","volume":"34","author":"Firth","year":"1983","journal-title":"Res Vet Sci"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.2042-3306.1992.tb02873.x","article-title":"Aretrospectivestudyof192horses affected with septic arthritis\/tenosynovitis","volume":"24","author":"Schneider","year":"1992","journal-title":"Equine Vet J"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1751-0813.2012.01000.x","article-title":"Surgical treatment of septic physitis in 17 foals","volume":"90","author":"Hall","year":"2012","journal-title":"Aust Vet J"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/eve.12616","article-title":"Haematogenous septic arthritis in foals: short- and long-term outcome and analysis of factors affecting prognosis","volume":"29","author":"Wright","year":"2017","journal-title":"Equine Vet Educ"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/B978-0-323-48420-6.00086-7","article-title":"Synovial and osseous infection","volume-title":"Equine Surgery","author":"Richardson","year":"2019"},{"key":"ref39","article-title":"The development of the report was overseen by the WHO Antimicrobial Resistance Division","volume-title":"The revision was completed at the 8th AGISAR meeting in Utrecht, the Netherlands","author":"Gonzalez-Zorn","year":""},{"key":"ref40","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/nyas.14058","article-title":"Critically important antibiotics: criteria and approaches for measuring and reducing their use in food animal agriculture","volume":"1441","author":"Scott","year":"2019","journal-title":"Ann N Y Acad Sci"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"629627","DOI":"10.3389\/fvets.2021.629627","article-title":"Meropenem administered via intravenous regional limb perfusion for orthopedic Sepsis in horses: a clinical retrospective study","volume":"8","author":"Mosichuk","year":"2021","journal-title":"Front Vet Sci"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2746\/095777308X338893","article-title":"Overview of the use of antimicrobials for the treatment of bacterial infections in horses","volume":"20","author":"Haggett","year":"2008","journal-title":"Equine Vet Educ"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/01.blo.0000229324.75911.c7","article-title":"Toxic effects of gentamicin on marrow-derived human mesenchymal stem cells","volume":"452","author":"Chang","year":"2006","journal-title":"Clin Orthop Relat Res"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1002\/jor.21343","article-title":"Effect of various concentrations of antibiotics on osteogenic cell viability and activity","volume":"29","author":"Rathbone","year":"2011","journal-title":"J Orthop Res"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.2042-3306.2011.00437.x","article-title":"The in vitro effects of antibiotics on cell viability and gene expression of equine bone marrow-derived mesenchymal stromal cells","volume":"44","author":"Parker","year":"2012","journal-title":"Equine Vet J"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.tiv.2014.10.013","article-title":"Antibiotics delay in vitro human stem cell regrowth","volume":"29","author":"Turani","year":"2015","journal-title":"Toxicol in Vitro"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.joca.2012.11.010","article-title":"Effects of doxycycline on mesenchymal stem cell chondrogenesis and cartilage repair","volume":"21","author":"Lee","year":"2013","journal-title":"Osteoarthr Cartil"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/scrt228","article-title":"Effective combination of human bone marrow mesenchymal stemcells and minocycline in experimental autoimmune encephalomyelitis mice","volume":"4","author":"Hou","year":"2013","journal-title":"Stem Cell Res Ther"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13287-017-0623-11186\/scrt228","article-title":"Minocycline modulates NF\u03baB phosphorylation and enhances antimicrobial activity against Staphylococcus aureus in mesenchymal stromal\/stem cells","volume":"8","author":"Guerra","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.tvjl.2018.07.004","article-title":"Practical considerations for clinical use of mesenchymal stem cells: from the laboratory to the horse","volume":"238","author":"Barrachina","year":"2018","journal-title":"Vet J"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.tvjl.2013.04.018","article-title":"Therapeutic use of stem cells in horses: which type, how, and when?","volume":"197","author":"Schnabel","year":"2013","journal-title":"Vet J."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.cveq.2023.06.008","article-title":"Overview of equine stem cells: sources, practices, and potential safety concerns","volume":"39","author":"Koch","year":"2023","journal-title":"Vet Clin North Am Equine Pract"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1080\/01652176.2013.873963","article-title":"Canine mesenchymal stem cells: state of the art, perspectives as therapy for dogs and as a model for man","volume":"33","author":"de Bakker","year":"2013","journal-title":"Vet Q"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.3390\/ijms18122522","article-title":"Impact of antibiotics on the proliferation and differentiation of human adipose-derived mesenchymal stem cells","volume":"18","author":"Skubis","year":"2017","journal-title":"Int J Mol Sci"}],"container-title":["Frontiers in Veterinary Science"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2026.1734585\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T05:43:08Z","timestamp":1772602988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fvets.2026.1734585\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":54,"alternative-id":["10.3389\/fvets.2026.1734585"],"URL":"https:\/\/doi.org\/10.3389\/fvets.2026.1734585","relation":{},"ISSN":["2297-1769"],"issn-type":[{"value":"2297-1769","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"article-number":"1734585"}}